|
|
| | Dexelvucitabine Basic information |
| Product Name: | Dexelvucitabine | | Synonyms: | Dexelvucitabine;2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine;4-AMINO-5-FLUORO-1-[(2R,5S)-5-(HYDROXYMETHYL)-2,5-DIHYDROFURAN-2-YL]PYRIMIDIN-2(1H)-ONE;Cytidine,2',3'-didehydro-2',3'-dideoxy-5-fluoro-;INCB 8721;RA 131423;Reverset;YZ 817 | | CAS: | 134379-77-4 | | MF: | C9H10FN3O3 | | MW: | 227.19 | | EINECS: | | | Product Categories: | | | Mol File: | 134379-77-4.mol |  |
| | Dexelvucitabine Chemical Properties |
| Boiling point | 394.9±52.0 °C(Predicted) | | density | 1.66±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:0.0(Max Conc. mg/mL);0.0(Max Conc. mM) | | pka | 14.28±0.10(Predicted) |
| | Dexelvucitabine Usage And Synthesis |
| Uses | Treatment of HIV-1 and HIV-2 infection. | | Uses | Dexelvucitabine is a nucleoside reverse transcriptase inhibitor (NRTI) which had the potential to inhibit HIV-1 replication. The drug was discontinued due to evidence that it causes damage to the pancreas. | | Brand name | Reverset (Incyte). |
| | Dexelvucitabine Preparation Products And Raw materials |
|